ZINZINO AB (PUBL): Share subscription due to warrants

By Cision
Zinzino

In the option program Zinzino's general meeting resolved on 31 May 2022, 34,500 B shares have been subscribed (series 2022/2027:1).
The price per share amounted to SEK 56 and in total Zinzino's equity was raised SEK by 1,932,000.
 

In the option program Zinzino's general meeting resolved on 31 May 2022, 2143 B shares have been subscribed (series 2022/2027:2). The price per share amounted to SEK 56 and in total Zinzino's equity was raised by SEK 120,008.
 

The total number of B-shares increased by 36,643 to 34,922,597.
The total number of shares after the increase was 39,435,989.
The dilution amounted to 0.09 percent. Zinzino's share capital increased to SEK 3,943,598,90.

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 707 900 174, fredrik.nielsen@zinzino.com

Pictures for publication free of charge: marketing@zinzino.com

Certified Adviser: Carnegie Investment Bank AB (publ)

Zinzino is a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements. Listed on the Nasdaq First North Premier Growth Market, the company's test-based, personalized nutrition strategy empowers individuals to take charge of their long-term health with science-based insights and targeted solutions. Its third-party validated products are available through direct sales distributors in more than 100 markets worldwide. Zinzino's headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.

https://news.cision.com/zinzino/r/zinzino-ab--publ--share-subscription-due-to-warrants%2Cc4409989

2610 Press release Share subscription due to warrants fall EN

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.